An MDL Panel ruled this week that any Actos lawsuits filed in federal court in Maryland will be consolidated in Louisiana.
Actos is another drug for type 2 diabetes that has helped treat diabetes but can get the patient into problems that they did not anticipate (Avandia has also had its share of problems). With Actos, studies have shown that people who take Actos for more than a year are 40 percent more likely to develop bladder cancer than those never exposed to Actos.
Actos does an effective job of treating diabetes. Actos improves blood sugar levels by increasing the body’s sensitivity to insulin in patients who have been diagnosed with type 2 Diabetes. Clearly, diabetes is a serious disease and the medications to treat diabetes come with – as most medications do – risk. Certainly, if you have life-threatening diabetes and Actos is the only drug that works for you, maybe you take on otherwise unacceptable risks. I get that. But Actos users did not sign up for this risk of bladder cancer. There are too many patients over the years that would not have used Actos if they knew it caused bladder cancer.
2018 Update: Most of these cases will be resolved after a settlement offer in excess of $2 billion. I suspect it is too late for most to file a claim. But if you want to find out, you really should hurry because you could lose your rights any minute now.
2018 Update #2: Invokana is the latest diabetes drug under siege.